Reaction
Paper #2
Starting
a biomedical research institute in Korea
(KAIST
Improvement of Biological Science in
Mar.
06 2008
“Pali-Pali”: Passion
or Hastiness
(Fast Improvement of Biological Science in
Social and cultural factors, such as the
aggressive mentality of the Korean people, high awareness of the challenges of
globalization and political as well as historical contexts played the decisive
role in its dynamic acceptance of new technologies (Aizu, 2002). The term
“Pali-Pali: fast-fast”, explains the basic psychological and behavioral pattern
of Korean people. In addition, Korean homogeneous and group oriented social
context lead them into pursuing or catching up a certain trend. In the realm of
innovation diffusion, these mentalities induce the fierce competition or fast
reproduction in the society (Lau, 2005).
As one of returning sea-turtles from the
Burgeoning
(1982~1991)
When
Dr. Yoo returned
Knowledge
transferring (1992~1998)
During
1990’s,
Through out
the world, the “developing countries” are attempting in a relatively brief span
of time to narrow the gap between themselves and those nations with a richer
technology and a higher standard of living. To achieve this, they are launching
and carrying forward nation-wide programs of change and are inviting from
outside thousands of specialist to strengthen these programs… It is sometimes
assumed that understanding the change-agent
role in any program for social change means the ability to apply techniques of
change or to speak glibly of the strategy of change. This is a part of the
role, to be sure, but only a narrow part… thus far, techniques and strategy
have not usually been considered in their effects upon other programs… or in
their effects upon other aspects of life than the one to which action is
directed
As a change agent of Bio-medical innovation in
From Quantity
to Quality (1999~2004)
On 1998, the economic bubble was burst and
Changing
the assessment system made a corner stone for biomedical research activities,
many researchers focus on not only the quantity but also the quality of their
research.
From
Laboratory to Industry (2005~2008)
Commercialization is the key activity in an
innovation. Dr. Yoo established GenExel, the world largest transgenic
Drosophila library on 2005 and it was listed on KOSTAQ (Korean version of
NASDAQ). He believes that research outputs should be commercialized to sustain
the future research capabilities. By strong support from Korean government, the
company is focusing in developing new biological drugs including humanized
anti-bodies and encouraging innovation activities of researchers by running
animal model facility.
Lucrative
future?
Founding the Graduate School of Biomedical
Science and Engineering in KAIST on 1999, the Korean biomedical innovation actions
seems have a lucrative future. The institute gathered top bio-medical
scientists and engineers from all over the world taking a role of brain sink
for returning sea turtles. In addition, a research oriented hospital, named
Pappalardo will be established on 2011. The hospital will be a big test bench
for new anti-body drugs and it will be one of the a core research cluster at
Dae-deok region. However, Dr. Yoo is not underestimating the challenges. He
pointed out three major challenges of bio-medical innovation in
First,
he concerned about poor research integrity in
Second,
unstructured grant design discourage the innovation capability. Although the
R&D budget of
Third,
Dr. Yoo is worrying about bad perception of being a Scientist or Engineer in
But
he is seeing a bright side. When he published a easy handbook book to spread
the bio-medical knowledge for general public, he got a great amount of
recognition from young students. His book motivated them and they decided to
study the bio-medical science. He strongly suggests many scientists and
engineers should try reducing the gap between general public and them.
Discussion
From Dr. Yoo’s session, I realized that
Biomedical innovation activities are quite successful but it also bear some
flaws. The “Pali-Pali: Fast-Fast” culture in
So,
change-agent who hopes to make a successful innovation should consider their
critical roles in an innovation action as well as the social impacts of their
activities. Dr. Yoo’s case proves it.
Summary of Workshop
Chronology of
Korean Bio-Tech Innovation
Stage |
Period |
Policy
& Fund |
Key
Activities |
Burgeoning |
1982 ~ 1991 |
-
R&D budget $230 mil. (1.6% from national
budget) -
Maximum Grant for Bio scientist ($9,000 /
year) -
Limited resources (No PCR instrument, No basic
understanding about DNA technology) -
Concerned about the number of international
journal publication |
-
Established basic infrastructure l Importing
basic instrument from the l Sustaining
research networks with the U.S. University -
Renovate Korean Bio-medical academy l Networking
with peer researchers in the field l Setup
rigorous academic evaluation |
Knowledge transferring |
1992~1998 |
-
R&D budget overcome 2% from national
budget -
1992, Start BMW (Biomedical Workshop) -
1994, First grant from Government for
Bio-technology -
Concern about the number of SCI publication |
-
Transferring bio-medical knowledge to Korean
Medical Doctors through national-wide five day molecular biology training
course workshop -
Since 1992, more than 1,120 medical doctors
participated the course and got knowledge about advanced bio-technology -
Based on a success of this workshop,
BioMedical Research center planned on 1996 |
From Quantity to
Quality |
1999~2004 |
-
R&D budget overcome 3% from national
budget -
Concern about the “Impact factor” of journals -
Focused on recruiting top-tier Korean
scientists and engineers |
-
The BioMedical research center was established
on KAIST campus on 1999 -
Encouraging publishing at qualified academic
journal which have high impact factors |
From laboratory to
industry |
2005~2008 |
-
R&D budget overcome 4% from national
budget -
Strengthened the research integrity after SNU’s
misconduct -
Government announced the Biotech is one of the
new technology for future for |
-
Established GenExel (world’s largest transgenic
Drosophila library) -
Listed KOSDAQ -
Developing new biologic drugs including
humanized antibodies -
Integrating research outputs from laboratory
and industrial innovation |
Lucrative future |
|
-
2011, the R&D budget will reach 4.5% from
national budget |
-
-
Pappalardo hospital |
References
Aizu,
Lau, T., Kim, S. W., & Atkin, D. (2005). An examination of factors contributing to
Roger, E., 1962. Diffusion of Innovations. Free
Press, Chap IX.
댓글